Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Scott H, Visovatti"'
Autor:
Kellie Morland, Christian Gerges, Jean Elwing, Scott H. Visovatti, Jason Weatherald, Kari R. Gillmeyer, Sandeep Sahay, Stephen C. Mathai, Athénaïs Boucly, Paul G. Williams, Sivadasanpillai Harikrishnan, Evan P. Minty, Lukas Hobohm, Arun Jose, Roberto Badagliacca, Edmund M. T. Lau, Zhi‐Cheng Jing, Rebecca R. Vanderpool, Charles Fauvel, Jose Leonidas Alves Jr., Geoff Strange, Tomas Pulido, Junyan Qian, Mengtao Li, Valentina Mercurio, Jason G. E. Zelt, Victor M. Moles, Meghan M. Cirulis, Sylvia M. Nikkho, Raymond L. Benza, C. Gregory Elliott
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 4, Pp n/a-n/a (2023)
Abstract This manuscript on real‐world evidence (RWE) in pulmonary hypertension (PH) incorporates the broad experience of members of the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative Real‐World Evidence Working Gr
Externí odkaz:
https://doaj.org/article/cbfc593f3e3c499eb6df1025f764229f
Autor:
Nishant Jain, Muhammad A. Sheikh, Divyansh Bajaj, Whitney Townsend, Richard Krasuski, Eric Secemsky, Saurav Chatterjee, Victor Moles, Prachi P. Agarwal, Jonathan Haft, Scott H. Visovatti, Thomas M. Cascino, Kenneth Rosenfield, Brahmajee K. Nallamothu, Vallerie V. Mclaughlin, Vikas Aggarwal
Publikováno v:
JACC: Cardiovascular Interventions. 16:976-983
Autor:
Thomas M. Cascino, Vallerie V. McLaughlin, Caroline R. Richardson, Nilofar Behbahani-Nejad, Victor M. Moles, Scott H. Visovatti, Elizabeth A. Jackson
Publikováno v:
Pulmonary Circulation, Vol 9 (2019)
Patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) have low levels of physical activity (PA). Increased PA has health benefits including improved quality of life. This study aimed to identify
Externí odkaz:
https://doaj.org/article/3ed904565e2a46a2b73140944e947bdd
Autor:
Scott H. Visovatti
Publikováno v:
Interventional Cardiology Clinics.
Autor:
Sara Jaafar, Dinesh Khanna, Scott H. Visovatti, Suiyuan Huang, Dharshan Vummidi, Vallerie V. McLaughlin, Amber Young, Vivek Nagaraja, Victor M. Moles
Publikováno v:
Arthritis Rheumatol
Objective Pulmonary arterial hypertension (PAH) is one of the leading causes of mortality in systemic sclerosis (SSc). This study was undertaken to assess predictive accuracies of the DETECT algorithm and the 2015 European Society of Cardiology/Europ
Autor:
Nimai Patel, Syed N. Hyder, Erinleigh Michaud, Victor Moles, Prachi P. Agarwal, Kenneth Rosenfield, Kohtaro Abe, Jonathan Haft, Scott H. Visovatti, Thomas M. Cascino, William R. Auger, Vallerie V. Mclaughlin, Vikas Aggarwal
Publikováno v:
Journal of the Society for Cardiovascular Angiography & Interventions. 1:100429
Autor:
Dinesh Khanna, Eric S. White, Vallerie V. McLaughlin, Holly Wilhalme, Amber Young, Kate Homer, Scott H. Visovatti, Kevin R. Flaherty, Dharshan Vummidi
Publikováno v:
Arthritis Rheumatol
Objective Systemic sclerosis (SSc) is associated with interstitial lung disease (ILD) and pulmonary hypertension (PH). This study was undertaken to determine the prevalence, characteristics, treatment, and outcomes of PH in a cohort of patients with
Autor:
Michael Holinstat, Anuli C. Anyanwu, Raymond Zhao, J. Michelle Kahlenberg, Sharon Koonse, Hui Liao, Yogendra Kanthi, Benjamin E. Tourdot, Benjamin N. Jacobs, Scott H. Visovatti, Srilakshmi Yalavarthi, Alison L. Banka, Liguo Chi, Vinita Yadav, David J. Pinsky, Jason S. Knight
Publikováno v:
Journal of Clinical Investigation. 129:2872-2877
Deep vein thrombosis (DVT), caused by alterations in venous homeostasis is the third most common cause of cardiovascular mortality; however, key molecular determinants in venous thrombosis have not been fully elucidated. Several lines of evidence ind
Autor:
Victor M. Moles, Caroline R. Richardson, Thomas Cascino, Scott H. Visovatti, Vallerie V. McLaughlin, Elizabeth A. Jackson, Nilofar Behbahani-Nejad
Publikováno v:
Pulmonary Circulation, Vol 9 (2019)
Pulmonary Circulation
Pulmonary Circulation
Patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) have low levels of physical activity (PA). Increased PA has health benefits including improved quality of life. This study aimed to identify
Autor:
Ryan Sanderson, Scott H. Visovatti, Nektarios Vasilottos, Alexander R. Zheutlin, Christopher Lewis
Publikováno v:
Pulmonary Hypertension ISBN: 9783030527860
Pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD-PAH) is a devastating condition that may progress rapidly to cause right ventricular dysfunction, resulting in significant morbidity and mortality. The pathobiology,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f602b87cbe6f1b66098a3b7b1ccccb58
https://doi.org/10.1007/978-3-030-52787-7_3
https://doi.org/10.1007/978-3-030-52787-7_3